| Unaudited Reconciliation of IFRS to Non-IFRS | |||||||||||
| Three Months Ended | |||||||||||
| (in millions USD) | September 30, 2023 | June 30, 2023 | September 30, 2022 | ||||||||
| Net Revenue | $ | 1,852 | $ | 1,845 | $ | 2,074 | |||||
| Gross profit | $ | 529 | $ | 532 | $ | 610 | |||||
| Gross profit margin | 28.6 | % | 28.8 | % | 29.4 | % | |||||
| Share-based compensation | $ | 12 | $ | 14 | $ | 11 | |||||
| Adjusted gross profit (1) | $ | 541 | $ | 546 | $ | 621 | |||||
| Adjusted gross margin (1) | 29.2 | % | 29.6 | % | 29.9 | % | |||||
| Selling, general and administrative | $ | 143 | $ | 132 | $ | 129 | |||||
| Share-based compensation | $ | 25 | $ | 24 | $ | 15 | |||||
| Adjusted selling, general and administrative | $ | 118 | $ | 108 | $ | 114 | |||||
| Research and development | $ | 108 | $ | 106 | $ | 124 | |||||
| Share-based compensation | $ | 7 | $ | 6 | $ | 6 | |||||
| Adjusted research and development (1) | $ | 101 | $ | 100 | $ | 118 | |||||
| Operating profit | $ | 261 | $ | 275 | $ | 357 | |||||
| Operating profit margin | 14.1 | % | 14.9 | % | 17.2 | % | |||||
| Share-based compensation | $ | 44 | $ | 44 | $ | 32 | |||||
| Restructuring charges | $ | 17 | $ | 19 | — | ||||||
| Adjusted operating profit (1) | $ | 322 | $ | 338 | $ | 389 | |||||
| Adjusted operating profit margin (1) | 17.4 | % | 18.3 | % | 18.8 | % | |||||
| Net income | $ | 249 | $ | 237 | $ | 336 | |||||
| Net income margin | 13.4 | % | 12.8 | % | 16.2 | % | |||||
| Share-based compensation | $ | 44 | $ | 44 | $ | 32 | |||||
| Restructuring charges | $ | 17 | $ | 19 | — | ||||||
| Income tax effect (2) | $ | (2 | ) | $ | (3 | ) | $ | — | |||
| Adjusted net income (1) (3) | $ | 308 | $ | 297 | $ | 368 | |||||
| Adjusted net income margin (1) | 16.6 | % | 16.1 | % | 17.7 | % | |||||
| Diluted earnings per share | $ | 0.45 | $ | 0.43 | $ | 0.61 | |||||
| Share-based compensation | $ | 0.08 | $ | 0.08 | $ | 0.06 | |||||
| Restructuring charges | $ | 0.03 | $ | 0.03 | — | ||||||
| Income tax effect | $ | (0.01 | ) | $ | (0.01 | ) | — | ||||
| Diluted shares outstanding | 556 | 556 | 553 | ||||||||
| Adjusted diluted earnings per share (1) | $ | 0.55 | $ | 0.53 | $ | 0.67 | |||||
| Net cash provided by operating activities | $ | 416 | $ | 546 | |||||||
| Less: Purchase of property, plant and equipment and intangible assets | $ | 323 | $ | 400 | |||||||
| Free cash flow (1) | $ | 93 | $ | 146 | |||||||
| (1) Adjusted gross profit, adjusted selling, general and administrative, adjusted research and development expense, adjusted operating profit, adjusted operating expense (calculated by subtracting adjusted operating profit from adjusted gross profit), adjusted net income, adjusted diluted earnings per share, free cash flow and any related margins are all Non-IFRS measures. See “Financial Measures (Non-IFRS)” for a discussion of why we believe these Non-IFRS measures are useful. | |||||||||||
| (2) Relates to restructuring charges. | |||||||||||
| (3) Reflects change to adjusted net income definition discussed in more detail elsewhere in this release. | |||||||||||
